BBCNEWS BBC News at Ten June 4, 2024 21:06:00
Due to brain swelling or bleeding. so the risks and benefits will need to be carefully assessed by regulators, who are already looking at donanemab and families will need to make that assessment. but for many, faced with a partner or parent in the early stages of alzheimer's, this drug could help a loved one stay independent for longer and as you saw in my report with mike and his family, it offers hope to those faced with these awful disease. there is a second alzheimer's which works in a similar way which is going through the approval process. it is already licensed in the us, where it costs...